Annual Operating Profit
-$63.04 M
+$39.58 M+38.57%
31 December 2023
Summary:
Standard BioTools annual operaing income is currently -$63.04 million, with the most recent change of +$39.58 million (+38.57%) on 31 December 2023. During the last 3 years, it has risen by +$4.42 million (+6.55%). LAB annual operating profit is now -332.57% below its all-time high of -$14.57 million, reached on 01 December 2010.LAB Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$24.30 M
+$17.69 M+42.13%
30 September 2024
Summary:
Standard BioTools quarterly operating income is currently -$24.30 million, with the most recent change of +$17.69 million (+42.13%) on 30 September 2024. Over the past year, it has dropped by -$9.39 million (-63.01%). LAB quarterly operating profit is now -1108.86% below its all-time high of -$2.01 million, reached on 01 December 2010.LAB Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$119.93 M
-$6.79 M-6.00%
30 September 2024
Summary:
Standard BioTools TTM operating income is currently -$119.93 million, with the most recent change of -$6.79 million (-6.00%) on 30 September 2024. Over the past year, it has dropped by -$56.89 million (-90.24%). LAB TTM operating profit is now -3066.81% below its all-time high of -$3.79 million, reached on 01 December 2009.LAB TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LAB Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -63.0% | -90.2% |
| 3 y3 years | +6.5% | -115.8% | -77.8% |
| 5 y5 years | -21.6% | -164.7% | -131.3% |
LAB Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.6% | -115.8% | +42.1% | -90.2% | at low |
| 5 y | 5 years | -23.5% | +38.6% | -344.7% | +42.1% | -176.9% | at low |
| alltime | all time | -332.6% | +38.6% | -1108.9% | +42.1% | -3066.8% | at low |
Standard BioTools Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.30 M(-42.1%) | -$119.93 M(+6.0%) |
| June 2024 | - | -$41.99 M(+8.4%) | -$113.14 M(+31.1%) |
| Mar 2024 | - | -$38.73 M(+159.9%) | -$86.33 M(+36.9%) |
| Dec 2023 | -$63.04 M(-38.6%) | -$14.91 M(-14.9%) | -$63.04 M(-2.4%) |
| Sept 2023 | - | -$17.51 M(+15.3%) | -$64.61 M(-11.1%) |
| June 2023 | - | -$15.18 M(-1.7%) | -$72.71 M(-24.1%) |
| Mar 2023 | - | -$15.44 M(-6.3%) | -$95.79 M(-11.2%) |
| Dec 2022 | -$102.62 M(+52.1%) | -$16.48 M(-35.6%) | -$107.85 M(+5.1%) |
| Sept 2022 | - | -$25.61 M(-33.1%) | -$102.63 M(+6.2%) |
| June 2022 | - | -$38.26 M(+39.1%) | -$96.64 M(+27.8%) |
| Mar 2022 | - | -$27.50 M(+144.3%) | -$75.64 M(+12.1%) |
| Dec 2021 | -$67.46 M(+32.2%) | -$11.26 M(-42.6%) | -$67.46 M(-7.7%) |
| Sept 2021 | - | -$19.61 M(+13.6%) | -$73.10 M(+24.0%) |
| June 2021 | - | -$17.27 M(-10.6%) | -$58.96 M(+6.4%) |
| Mar 2021 | - | -$19.32 M(+14.3%) | -$55.41 M(+8.6%) |
| Dec 2020 | -$51.04 M(-1.5%) | - | - |
| Dec 2020 | - | -$16.90 M(+209.4%) | -$51.04 M(+17.8%) |
| Sept 2020 | - | -$5.46 M(-60.2%) | -$43.31 M(-16.2%) |
| June 2020 | - | -$13.73 M(-8.1%) | -$51.66 M(-1.7%) |
| Mar 2020 | - | -$14.94 M(+62.7%) | -$52.58 M(+1.4%) |
| Dec 2019 | -$51.84 M(+7.6%) | - | - |
| Dec 2019 | - | -$9.18 M(-33.5%) | -$51.84 M(-3.6%) |
| Sept 2019 | - | -$13.82 M(-5.6%) | -$53.78 M(+4.2%) |
| June 2019 | - | -$14.64 M(+3.0%) | -$51.59 M(+3.7%) |
| Mar 2019 | - | -$14.21 M(+27.8%) | -$49.74 M(+3.3%) |
| Dec 2018 | -$48.16 M(-17.5%) | -$11.12 M(-4.4%) | -$48.16 M(+5.2%) |
| Sept 2018 | - | -$11.63 M(-9.0%) | -$45.78 M(-8.0%) |
| June 2018 | - | -$12.79 M(+1.2%) | -$49.76 M(-6.9%) |
| Mar 2018 | - | -$12.63 M(+44.6%) | -$53.46 M(-8.4%) |
| Dec 2017 | -$58.36 M | -$8.73 M(-44.0%) | -$58.36 M(-13.3%) |
| Sept 2017 | - | -$15.60 M(-5.4%) | -$67.32 M(-4.1%) |
| June 2017 | - | -$16.49 M(-6.0%) | -$70.20 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$17.54 M(-0.9%) | -$71.86 M(-1.8%) |
| Dec 2016 | -$73.19 M(+35.2%) | -$17.70 M(-4.3%) | -$73.19 M(+5.8%) |
| Sept 2016 | - | -$18.48 M(+1.9%) | -$69.19 M(+10.7%) |
| June 2016 | - | -$18.14 M(-3.9%) | -$62.49 M(+5.9%) |
| Mar 2016 | - | -$18.87 M(+37.8%) | -$59.01 M(+9.0%) |
| Dec 2015 | -$54.14 M(+31.6%) | -$13.69 M(+16.1%) | -$54.14 M(+7.7%) |
| Sept 2015 | - | -$11.79 M(-19.6%) | -$50.28 M(-2.4%) |
| June 2015 | - | -$14.66 M(+4.7%) | -$51.54 M(+4.6%) |
| Mar 2015 | - | -$14.00 M(+42.4%) | -$49.26 M(+19.7%) |
| Dec 2014 | -$41.14 M(+136.6%) | -$9.83 M(-24.6%) | -$41.14 M(+15.3%) |
| Sept 2014 | - | -$13.05 M(+5.4%) | -$35.68 M(+34.2%) |
| June 2014 | - | -$12.38 M(+110.4%) | -$26.59 M(+46.1%) |
| Mar 2014 | - | -$5.88 M(+34.4%) | -$18.20 M(+4.7%) |
| Dec 2013 | -$17.39 M(-3.8%) | -$4.38 M(+10.8%) | -$17.39 M(+5.4%) |
| Sept 2013 | - | -$3.95 M(-1.0%) | -$16.50 M(+0.3%) |
| June 2013 | - | -$3.99 M(-21.3%) | -$16.46 M(-2.3%) |
| Mar 2013 | - | -$5.07 M(+45.1%) | -$16.86 M(-6.7%) |
| Dec 2012 | -$18.07 M(+16.1%) | -$3.49 M(-10.6%) | -$18.07 M(+2.9%) |
| Sept 2012 | - | -$3.91 M(-10.9%) | -$17.56 M(-0.8%) |
| June 2012 | - | -$4.39 M(-30.2%) | -$17.70 M(+4.3%) |
| Mar 2012 | - | -$6.28 M(+110.9%) | -$16.97 M(+9.0%) |
| Dec 2011 | -$15.57 M(+6.8%) | -$2.98 M(-26.5%) | -$15.57 M(+6.6%) |
| Sept 2011 | - | -$4.05 M(+11.0%) | -$14.60 M(+7.0%) |
| June 2011 | - | -$3.65 M(-25.1%) | -$13.64 M(-4.0%) |
| Mar 2011 | - | -$4.88 M(+142.7%) | -$14.21 M(-2.5%) |
| Dec 2010 | -$14.57 M(-19.2%) | -$2.01 M(-35.1%) | -$14.57 M(-10.9%) |
| Sept 2010 | - | -$3.10 M(-26.7%) | -$16.35 M(+23.4%) |
| June 2010 | - | -$4.23 M(-19.3%) | -$13.25 M(+46.8%) |
| Mar 2010 | - | -$5.24 M(+38.3%) | -$9.03 M(+138.3%) |
| Dec 2009 | -$18.04 M(-38.9%) | -$3.79 M | -$3.79 M |
| Dec 2008 | -$29.54 M(+25.6%) | - | - |
| Dec 2007 | -$23.53 M(+8.6%) | - | - |
| Dec 2006 | -$21.66 M | - | - |
FAQ
- What is Standard BioTools annual operaing income?
- What is the all time high annual operating profit for Standard BioTools?
- What is Standard BioTools quarterly operating income?
- What is the all time high quarterly operating profit for Standard BioTools?
- What is Standard BioTools quarterly operating profit year-on-year change?
- What is Standard BioTools TTM operating income?
- What is the all time high TTM operating profit for Standard BioTools?
- What is Standard BioTools TTM operating profit year-on-year change?
What is Standard BioTools annual operaing income?
The current annual operating profit of LAB is -$63.04 M
What is the all time high annual operating profit for Standard BioTools?
Standard BioTools all-time high annual operaing income is -$14.57 M
What is Standard BioTools quarterly operating income?
The current quarterly operating profit of LAB is -$24.30 M
What is the all time high quarterly operating profit for Standard BioTools?
Standard BioTools all-time high quarterly operating income is -$2.01 M
What is Standard BioTools quarterly operating profit year-on-year change?
Over the past year, LAB quarterly operating income has changed by -$9.39 M (-63.01%)
What is Standard BioTools TTM operating income?
The current TTM operating profit of LAB is -$119.93 M
What is the all time high TTM operating profit for Standard BioTools?
Standard BioTools all-time high TTM operating income is -$3.79 M
What is Standard BioTools TTM operating profit year-on-year change?
Over the past year, LAB TTM operating income has changed by -$56.89 M (-90.24%)